Autonomix Medical, Inc. (AMIX)
1.48
-0.04
(-2.63%)
USD |
NASDAQ |
Nov 06, 10:31
Autonomix Medical Enterprise Value : -2.636M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | -2.636M |
| November 04, 2026 | -2.587M |
| November 03, 2026 | -2.560M |
| November 02, 2026 | -2.549M |
| October 30, 2026 | -2.478M |
| October 29, 2026 | -2.354M |
| October 28, 2026 | -2.294M |
| October 27, 2026 | -2.337M |
| October 26, 2026 | -2.321M |
| October 23, 2026 | -2.148M |
| October 22, 2026 | -2.104M |
| October 21, 2026 | -2.066M |
| October 20, 2026 | -2.045M |
| October 19, 2026 | -2.023M |
| October 16, 2026 | -1.917M |
| October 15, 2026 | -1.871M |
| October 14, 2026 | -1.887M |
| October 13, 2026 | -1.828M |
| October 12, 2026 | -1.779M |
| October 09, 2026 | -1.773M |
| October 08, 2026 | -1.763M |
| October 07, 2026 | -1.611M |
| October 06, 2026 | -1.578M |
| October 05, 2026 | -1.540M |
| October 02, 2026 | -1.410M |
| Date | Value |
|---|---|
| October 01, 2026 | -1.334M |
| September 30, 2026 | -1.383M |
| September 29, 2026 | -1.426M |
| September 28, 2026 | -1.383M |
| September 25, 2026 | -1.28M |
| September 24, 2026 | -1.253M |
| September 23, 2026 | -1.302M |
| September 22, 2026 | -1.220M |
| September 21, 2026 | -1.264M |
| September 18, 2026 | -1.177M |
| September 17, 2026 | -1.139M |
| September 16, 2026 | -1.226M |
| September 15, 2026 | -1.177M |
| September 14, 2026 | -1.112M |
| September 11, 2026 | -1.090M |
| September 10, 2026 | -1.082M |
| September 09, 2026 | -0.9817M |
| September 08, 2026 | -0.9763M |
| September 04, 2026 | -0.9708M |
| September 03, 2026 | -0.922M |
| September 02, 2026 | -1.020M |
| September 01, 2026 | -0.8895M |
| August 31, 2026 | -0.8407M |
| August 28, 2026 | -0.575M |
| August 27, 2026 | -0.4069M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 224.21B |
| AngioDynamics, Inc. | 477.80M |
| Alphatec Holdings, Inc. | 1.734B |
| AtriCure, Inc. | 3.030B |
| Baxter International, Inc. | 19.28B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.728M |
| Total Expenses (Quarterly) | 2.728M |
| EPS Diluted (Quarterly) | -5.018 |
| Earnings Yield | -3.14K% |
| Normalized Earnings Yield | -3140.85 |